Genus plc (GENSY)
OTCMKTS · Delayed Price · Currency is USD
24.34
+1.34 (5.83%)
At close: Apr 11, 2025

Genus Statistics

Total Valuation

Genus has a market cap or net worth of 1.40 billion. The enterprise value is 1.73 billion.

Market Cap 1.40B
Enterprise Value 1.73B

Important Dates

The next estimated earnings date is Thursday, September 4, 2025.

Earnings Date Sep 4, 2025
Ex-Dividend Date Mar 10, 2025

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) -0.52%
Shares Change (QoQ) +0.50%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 60.25M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.67
PB Ratio 2.17
P/TBV Ratio 3.23
P/FCF Ratio 29.23
P/OCF Ratio 22.71
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.93, with an EV/FCF ratio of 36.17.

EV / Earnings -346.29
EV / Sales 1.94
EV / EBITDA 11.93
EV / EBIT 16.08
EV / FCF 36.17

Financial Position

The company has a current ratio of 1.94, with a Debt / Equity ratio of 0.58.

Current Ratio 1.94
Quick Ratio 1.26
Debt / Equity 0.58
Debt / EBITDA 3.29
Debt / FCF 7.77
Interest Coverage 3.26

Financial Efficiency

Return on equity (ROE) is -1.18% and return on invested capital (ROIC) is 4.63%.

Return on Equity (ROE) -1.18%
Return on Assets (ROA) 3.81%
Return on Invested Capital (ROIC) 4.63%
Return on Capital Employed (ROCE) 7.31%
Revenue Per Employee 240,226
Profits Per Employee -1,431
Employee Count 3,500
Asset Turnover 0.66
Inventory Turnover 4.63

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +2.48% in the last 52 weeks. The beta is 0.60, so Genus's price volatility has been lower than the market average.

Beta (5Y) 0.60
52-Week Price Change +2.48%
50-Day Moving Average n/a
200-Day Moving Average n/a
Relative Strength Index (RSI) n/a
Average Volume (20 Days) 113

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Genus had revenue of 840.79 million and -5.01 million in losses. Loss per share was -0.08.

Revenue 840.79M
Gross Profit 323.12M
Operating Income 77.87M
Pretax Income -6.89M
Net Income -5.01M
EBITDA 93.89M
EBIT 77.87M
Loss Per Share -0.08
Full Income Statement

Balance Sheet

The company has 59.34 million in cash and 372.57 million in debt, giving a net cash position of -313.23 million.

Cash & Cash Equivalents 59.34M
Total Debt 372.57M
Net Cash -313.23M
Net Cash Per Share n/a
Equity (Book Value) 646.49M
Book Value Per Share 9.82
Working Capital 158.62M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 61.72 million and capital expenditures -13.77 million, giving a free cash flow of 47.95 million.

Operating Cash Flow 61.72M
Capital Expenditures -13.77M
Free Cash Flow 47.95M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 38.43%, with operating and profit margins of 9.26% and -0.60%.

Gross Margin 38.43%
Operating Margin 9.26%
Pretax Margin -0.82%
Profit Margin -0.60%
EBITDA Margin 11.17%
EBIT Margin 9.26%
FCF Margin 5.70%

Dividends & Yields

This stock pays an annual dividend of 0.33, which amounts to a dividend yield of 1.37%.

Dividend Per Share 0.33
Dividend Yield 1.37%
Dividend Growth (YoY) 2.38%
Years of Dividend Growth 3
Payout Ratio n/a
Buyback Yield 0.52%
Shareholder Yield 1.89%
Earnings Yield -0.36%
FCF Yield 3.42%
Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Genus has an Altman Z-Score of 3.07.

Altman Z-Score 3.07
Piotroski F-Score n/a